An RNAi screen of Rho signalling networks identifies RhoH as a regulator of Rac1 in prostate cancer cell migration
2018 · BMC Biology · 32 citations
https://doi.org/10.1186/s12915-018-0489-4
R
Richard Allen
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
48
Papers
990
Citations
15
h-index
24
i10-index
Richard Allen is an academic researcher from Pfizer (United States). The author has contributed to research in topics: Computational Drug Discovery Methods & SARS-CoV-2 and COVID-19 Research & Liver Disease Diagnosis and Treatment. The author has an h-index of 15, co-authored 41 publications.
ORCID: 0000-0002-8038-9452Papers by this author
worksCurrent practices for QSP model assessment: an IQ consortium survey
2022 · Journal of Pharmacokinetics and Pharmacodynamics · 23 citations
https://doi.org/10.1007/s10928-022-09811-1
A quantitative systems pharmacology model of the pathophysiology and treatment of COVID-19 predicts optimal timing of pharmacological interventions
2023 · npj Systems Biology and Applications · 19 citations
https://doi.org/10.1038/s41540-023-00269-6
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat